Rigel Pharmaceuticals
RIGL
#6788
Rank
A$0.90 B
Marketcap
A$50.04
Share price
-3.22%
Change (1 day)
53.85%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): A$0.18 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are A$0.28 Billion. In 2024 the company made an earning of A$37.09 Million, an increase over its 2023 earnings that were of -A$25.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.18 B406.05%
2024 A$37.09 M-244.27%
2023 -A$25.72 Million-66.79%
2022 -A$77.43 Million340.73%
2021 -A$17.57 Million-56.15%
2020 -A$40.07 Million-57.34%
2019 -A$93.93 Million-7.66%
2018 -A$0.11 Billion-9.47%
2017 -A$0.12 Billion24.46%
2016 -A$90.28 Million23.63%
2015 -A$73.02 Million-43.29%
2014 -A$0.13 Billion2.5%
2013 -A$0.13 Billion
2010 A$53.42 M-133.97%
2009 -A$0.16 Billion-18.49%
2008 -A$0.2 Billion71.91%
2007 -A$0.12 Billion84.74%
2006 -A$60.75 Million-10.17%
2005 -A$67.63 Million-15.73%
2004 -A$80.26 Million39.29%
2003 -A$57.62 Million10.3%
2002 -A$52.24 Million48.3%
2001 -A$35.23 Million-2.13%
2000 -A$36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$11.63 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$18.47 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-A$0.16 Billion-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
-A$0.19 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA